Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Mandarin Oriental Washington D.C.

Jan 23, 2017 7:30 AM - Jan 25, 2017 3:15 PM

1330 Maryland Avenue, SW, Washington, DC 20024

Pharmacovigilance and Risk Management Strategies Conference

Session 9: Engaging the Customer - Health Care Providers

Session Chair(s)

Michael  Richardson, MD, FFPM, FRCP

Michael Richardson, MD, FFPM, FRCP

Senior Vice President, WorldWide Patient Safety

Bristol-Myers Squibb, United Kingdom

New data sources and methodologies are improving our ability to assess risk and risk-benefit balance associated with medical product use, but this information must be appropriately shared to facilitate decision making by all stakeholders, including health care providers and especially patients. How are risk and risk mitigation approaches most effectively shared with health care providers, and how can effective feedback on adverse events be best communicated to sponsors? What approaches to sharing benefit-risk information are most meaningful and useful to the patient in his or her decision making? What tools does FDA use to communicate with the public about drug safety and risks, and what impact have these messages had on health care professional and patient or consumer decision making? In this session, patient representatives and communication professionals from industry and FDA will explore how well current methods are working and how they can be improved.

Speaker(s)

Reema  Mehta, PharmD, MPH

Effective Risk Management Communications with Health Care Providers

Reema Mehta, PharmD, MPH

Pfizer Inc, United States

Senior Director, Head of Risk Management and Safety Surveillance Research

James A. Seaton

Patient Perspectives on Risk Benefit and Risk Management Messages

James A. Seaton

Seaton Associates, LLC, United States

Executive Consultant

Paula  Rausch, PhD, RN

FDA Risk Communications to the Public: Impact and Outcomes

Paula Rausch, PhD, RN

FDA, United States

Director, Division of Health Communications, Office of Communications, CDER

Sally  Okun, BSN, MHS, MBA, RN

Evaluating Drug Safety Communication: Research Gaps and Opportunities

Sally Okun, BSN, MHS, MBA, RN

Clinical Trials Transformation Initiative (CTTI), United States

Executive Director

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.